Lonza offers guidance for environmental infection control of Ebola Virus

Lonza lays claims to many disinfectants and disinfectant cleaners with supported label claims for viruses including those identified by U.S. CDC and within EN 14885:2006

Lonza, a leading manufacturer of disinfectants and disinfectant cleaners has provided some guidance on the use of its portfolio of disinfectants and disinfectant cleaners as part of an infection control programme for the Ebola virus.
On 1 August 2014, the US Centers for Disease Control and Prevention (CDC) released guidance titled “Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in U.S. Hospitals.”
The CDC states that, as part of the program of care of persons with probable or confirmed Ebola virus infections, hospitals are recommended to “Use a U.S. Environmental Protection Agency (EPA)-registered hospital disinfectant with a label claim for a non-enveloped virus (e.g., norovirus, rotavirus, adenovirus, poliovirus) to disinfect environmental surfaces in rooms of patients with suspected or confirmed Ebola virus infection.”
Separately, and in specific reference to “Environmental infection control,” the CDC has stated “Appropriate disinfectants for Ebola virus and other filoviruses include…hospital-grade quaternary ammonium…products.”
In addition, within Europe, the current EN 14885:2006 standard “Application of European Standards for Chemical Disinfectants and Antiseptics” stipulates that for a “virucidal” claim to be made for hard surface and instrument disinfectants, efficacy against poliovirus and adenovirus needs to be demonstrated using the EN 14476:2005 test protocol.
Lonza lays claims to many disinfectants and disinfectant cleaners with supported label claims for viruses including those identified by U.S. CDC and within EN 14885:2006. Lonza offers for sale disinfectants with specific claims against target organisms as approved for the jurisdiction in which each product is sold.
Lonza’s US product portfolio that meet the CDC guidance to use products having efficacy against non-enveloped viruses include Bardac 205M, Lonzagard HWS, Lonzagard R-82, Lonzagard RCS and Lonzagard Disinfectant Wipes. In Europe, Lonzagard DR-25aN Disinfectant Cleaner can make “virucidal” claims according to standards set by EN 14885:2006.

EH News Bureau

Comments (0)
Add Comment